Table 2.

Patient characteristics (N = 135 patients)

TotalCEBPA+CEBPAP
No. of patients 135 15 120  
Median age, y (range) 45  (15-64) 45  (22-63) 45  (15-64) .59* 
Sex (M/F) 71/64 10/5 61/59 .28 
WBC, ×109/L (range) 14  (0.6-400) 20  (2.2-170) 13  (0.6-400) .68* 
FAB subtypes     
 M0  
 M1 33 25 .02 
 M2 34 32  
 M4 19 16  
 M5 32 30  
 M6  
 M7  
 Unclassified  
Cytogenetics (MRC classification)    .062-153 
 Favorable 15 15  
  t(8;21)  
  Inv(16)  
 Intermediate 91 15 76  
 Adverse 14 14  
 Undetermined 15 15  
FLT3status    .54 
 Wild type 99 10 89  
 ITD 35 30  
Induction arm    .79 
 Standard 3 + 7 45 39  
 Double induction 47 43  
 Timed-sequential induction 43 38  
TotalCEBPA+CEBPAP
No. of patients 135 15 120  
Median age, y (range) 45  (15-64) 45  (22-63) 45  (15-64) .59* 
Sex (M/F) 71/64 10/5 61/59 .28 
WBC, ×109/L (range) 14  (0.6-400) 20  (2.2-170) 13  (0.6-400) .68* 
FAB subtypes     
 M0  
 M1 33 25 .02 
 M2 34 32  
 M4 19 16  
 M5 32 30  
 M6  
 M7  
 Unclassified  
Cytogenetics (MRC classification)    .062-153 
 Favorable 15 15  
  t(8;21)  
  Inv(16)  
 Intermediate 91 15 76  
 Adverse 14 14  
 Undetermined 15 15  
FLT3status    .54 
 Wild type 99 10 89  
 ITD 35 30  
Induction arm    .79 
 Standard 3 + 7 45 39  
 Double induction 47 43  
 Timed-sequential induction 43 38  
*

By the Mann-Whitney test.

By the Fisher exact test.

By the Fisher exact test comparing M1 subtype versus all other FAB subtypes.

F2-153

By the Fisher exact test performed on the 4-subgroup repartition, including favorable, intermediate, adverse, and undetermined cytogenetics.

Close Modal

or Create an Account

Close Modal
Close Modal